Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Guides ANDA Sponsors On Being “Easily Correctable”

Executive Summary

Draft guidance defines “easily correctable deficiencies” as those requiring a “modest expenditure of FDA resources and do not require a goal date extension, but a late response still could force an adjustment.

Advertisement

Related Content

ANDA Amendments Cannot Get Mid-Review Communications Like Full Applications - FDA
ANDA Amendments Cannot Get Mid-Review Communications Like Full Applications - FDA
ANDA Submissions Continue Yo-Yo Pattern, Unlike Approvals
ANDA Submissions Continue Yo-Yo Pattern, Unlike Approvals

Topics

Advertisement
UsernamePublicRestriction

Register

PS056259

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel